open access
Cancer incidence and mortality in Poland in 2020
, 12, 13, 14
Affiliations- Polish National Cancer Registry, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
- Faculty of Biomedical Engineering, Silesian University of Technology, Zabrze, Poland
- Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences, Warsaw, Poland
- Cancer Epidemiology and Primary Prevention Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
open access
Abstract
Introduction. Morbidity due to malignant neoplasms has been growing steadily during the last three decades, and cancer has become the second most widespread cause of death. The aim of this article is to present a summary of the epidemiological indicators of malignant neoplasms in Poland in 2020.
Material and methods. In the following report, we present the latest estimates of morbidity and mortality from cancer in Poland in 2020–2022 and a wide range of information on the occurrence of registered cancer cases and deaths in 2020, according to sex, age, cancer site, or Polish administrative division. Cancer data was collected by the National Cancer Registry and the Central Statistical Office.
Results. The PNCR received information about 146,181 new cases and 99,871 thousand cancer deaths in 2020. Compared to the previous year, the number of cancer cases decreased by about 12,000 in both sexes.
Conclusions. An important phenomenon that appeared in 2020 was the COVID-19 pandemic. It more than likely significantly influenced cancer cases under-registration.
Abstract
Introduction. Morbidity due to malignant neoplasms has been growing steadily during the last three decades, and cancer has become the second most widespread cause of death. The aim of this article is to present a summary of the epidemiological indicators of malignant neoplasms in Poland in 2020.
Material and methods. In the following report, we present the latest estimates of morbidity and mortality from cancer in Poland in 2020–2022 and a wide range of information on the occurrence of registered cancer cases and deaths in 2020, according to sex, age, cancer site, or Polish administrative division. Cancer data was collected by the National Cancer Registry and the Central Statistical Office.
Results. The PNCR received information about 146,181 new cases and 99,871 thousand cancer deaths in 2020. Compared to the previous year, the number of cancer cases decreased by about 12,000 in both sexes.
Conclusions. An important phenomenon that appeared in 2020 was the COVID-19 pandemic. It more than likely significantly influenced cancer cases under-registration.
Keywords
mortality; morbidity; neoplasms; Poland
About this articleTitle
Cancer incidence and mortality in Poland in 2020
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Other materials agreed with the Editors
Pages
129-145
Published online
2023-06-27
Page views
1782
Article views/downloads
1138
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2023;73(3):129-145.
Keywords
mortality
morbidity
neoplasms
Poland
Authors
Urszula Wojciechowska
Klaudia Barańska
Marta Miklewska
Joanna A. Didkowska
References (6)- https://stat.gov.pl/obszary-tematyczne/ludnosc/statystyka-przyczyn-zgonow/umieralnosc-i-zgony-wedlug-przyczyn-w-2020-roku,10,1.html.
- Wojciechowska U, Barańska K, Michalek IM, Olasek P, Miklewska M, Didkowska J. Nowotwory Złośliwe w Polsce w 2020 roku. Krajowy Rejestr Nowotworów 2022.
- World Health Organization. International Statistical Classification of Diseases and Related Health Problems. World Health Organization; 2015. https://apps.who.int/iris/handle/10665/246208 (22.03.2023).
- Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age Standardization of Rates: A new WHO Standard.
- European Commission. Eurostat. Revision of the European Standard Population: Report of Eurostat’s Task Force : 2013 Edition. Publications Office; 2013. https://data.europa.eu/doi/10.2785/11470 (25.10.2022).
- Bakouny Z, Paciotti M, Schmidt AL, et al. Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. JAMA Oncol. 2021; 7(3): 458–460.